SEARCH

SEARCH BY CITATION

References

  • 1
    Ince H, Nienaber CA. Future investigations in stem cell activation with granulocyte-colony-stimulating factor after myocardial infarction. Nat Clin Pract Cardiovasc Med. 2007;4(suppl 1):S119S122.
  • 2
    Ott HC, Taylor DA. From cardiac repair to cardiac regeneration—ready to translate? Expert Opin Biol Ther. 2006;6:867878.
  • 3
    Deindl E, Zaruba MM, Brunner S, et al. G-CSF administration after myocardial infarction in mice attenuates late ischemic cardiomyopathy by enhanced arteriogenesis. FASEB J. 2006;20:956958.
  • 4
    Zohlnhöfer D, Ott I, Mehilli J, et al. Stem cell mobilization by granulocyte colony-stimulating factor in patients with acute myocardial infarction: a randomized controlled trial. JAMA. 2006;295:10031010.
  • 5
    Takano H, Qin Y, Hasegawa H, et al. Effects of G-CSF on left ventricular remodeling and heart failure after acute myocardial infarction. J Mol Med. 2006;84:185193.
  • 6
    Ripa RS, Jorgensen E, Wang Y, et al. Stem cell mobilization induced by subcutaneous granulocyte-colony stimulating factor to improve cardiac regeneration after acute ST-elevation myocardial infarction: result of the double-blind, randomized, placebo-controlled stem cells in myocardial infarction (STEMMI) trial. Circulation. 2006;113:19831992.
  • 7
    Schachinger V, Erbs S, Elsasser A, et al. Intracoronary infusion of bone marrow-derived progenitor cells in acute myocardial infarction: a randomized, double-blind, placebo controlled multicenter trial (REPAIR-AMI). Circulation. 2005;112(suppl II):PII-3362.
  • 8
    Ince H, Petzsch M, Kleine HD, et al. Preservation from left ventricular remodeling by front-integrated revascularization and stem cell liberation in evolving acute myocardial infarction by use of granulocyte-colony-stimulating factor (FIRSTLINE-AMI). Circulation. 2005;112:30973106.
  • 9
    Hill JM, Bartunek J. The end of granulocyte colony-stimulating factor in acute myocardial infarction? Reaping the benefits beyond cytokine mobilization. Circulation. 2006;113:19261928.
  • 10
    Kloner RA. Attempts to recruit stem cells for repair of acute myocardial infarction: a dose of reality. JAMA. 2006;295:10581060.
  • 11
    Ince H, Nienaber CA. Granulocyte-colony-stimulating factor in acute myocardial infarction: future perspectives after FIRSTLINE-AMI and REVIVAL-2. Nat Clin Pract Cardiovasc Med. 2007;4(suppl 1):S114S118.
  • 12
    Metharom P, Doyle B, Caplice NM. Clinical trials in stem cell therapy: pitfalls and lessons for the future. Nat Clin Pract Cardiovasc Med. 2007;4(suppl 1):S96S99.
  • 13
    Zohlnhöfer D, Kastrati A, Schomig A. Stem cell mobilization by granulocyte-colony-stimulating factor in acute myocardial infarction: lessons from the REVIVAL-2 trial. Nat Clin Pract Cardiovasc Med. 2007;4(suppl 1):S106S109.
  • 14
    Ballard VL, Edelberg JM. Stem cells and the regeneration of the aging cardiovascular system. Circ Res. 2007;100:11161127.
  • 15
    Wojakowski W, Kucia M, Kazmierski M, et al. Circulating stem/progenitor cells in stable ischemic heart disease and acute coronary syndromes - relevant reparatory mechanism? Heart. 2007 Mar 29; [Epub ahead of print].
  • 16
    Vandervelde S, van Luyn MJ, Rozenbaum MH, et al. Stem cell-related cardiac gene expression early after murine myocardial infarction. Cardiovasc Res. 2007;73:783793.
  • 17
    Kovacic JC, Muller DW, Graham RM. Actions and therapeutic potential of G-CSF and GM-CSF in cardiovascular disease. J Mol Cell Cardiol. 2007;42:1933.
  • 18
    Misao Y, Takemura G, Arai M, et al. Importance of recruitment of bone marrow-derived CXCR4+ cells in post-infarct cardiac repair mediated by G-CSF. Cardiovasc Res. 2006;71:455465.
  • 19
    Harada M, Qin Y, Takano H, et al. G-CSF prevents cardiac remodeling after myocardial infarction by activating the Jak-Stat pathway in cardiomyocytes. Nat Med. 2005;11:305311.
  • 20
    Kurdi M, Booz GW. Can the protective actions of JAK-STAT in the heart be exploited therapeutically? Parsing the regulation of IL-6-type cytokine signaling. J Cardiovasc Pharmacol. In press.
  • 21
    Li Y, Takemura G, Okada H, et al. Treatment with granulocyte colony-stimulating factor ameliorates chronic heart failure. Lab Invest. 2006;86:3244.
  • 22
    Miyata S, Takemura G, Kawase Y, et al. Autophagic cardiomyocyte death in cardiomyopathic hamsters and its prevention by granulocyte colony-stimulating factor. Am J Pathol. 2006;168:386397.
  • 23
    Li Y, Fukuda N, Yokoyama S, et al. Effects of G-CSF on cardiac remodeling and arterial hyperplasia in rats. Eur J Pharmacol. 2006;549:98106.
  • 24
    Hou XW, Son J, Wang Y, et al. Granulocyte colony-stimulating factor reduces cardiomyocyte apoptosis and improves cardiac function in adriamycin-induced cardiomyopathy in rats. Cardiovasc Drugs Ther. 2006;20:8591.
  • 25
    Li L, Takemura G, Li Y, et al. Granulocyte colony stimulating factor improves left ventricular function of doxorubicin-induced cardiomyopathy. Lab Invest. 2007;87:440455.
  • 26
    Kuhlmann MT, Kirchhof P, Klocke R, et al. G-CSF/SCF reduces inducible arrhythmias in the infarcted heart potentially via increased connexin43 expression and arteriogenesis. J Exp Med. 2006;203:8797.
  • 27
    Lehrke S, Mazhari R, Durand DJ, et al. Aging impairs the beneficial effect of granulocyte colony-stimulating factor and stem cell factor on post-myocardial infarction remodeling. Circ Res. 2006;99:553560.
  • 28
    Capoccia BJ, Shepherd RM, Link DC. G-CSF and AMD3100 mobilize monocytes into the blood that stimulate angiogenesis in vivo through a paracrine mechanism. Blood. 2006;108:24382445.
  • 29
    Herbert KE, Walkley CR, Winkler IG, et al. Granulocyte colony-stimulating factor and an RARα specific agonist, VTP195183, synergize to enhance the mobilization of hematopoietic progenitor cells. Transplantation. 2007;83(4):375384.
  • 30
    Misao Y, Arai M, Ohno T, et al. Modification of post-myocardial infarction granulocyte-colony stimulating factor therapy with myelo-suppressives. Circ J. 2007;71:580590.
  • 31
    Cho HJ, Yoon YS. Synergism of hematopoietic cytokines for infarct repair. Circ Res. 2006;98:990992.
  • 32
    Dawn B, Guo Y, Rezazadeh A, et al. Postinfarct cytokine therapy regenerates cardiac tissue and improves left ventricular function. Circ Res. 2006;98:10981105.
  • 33
    Zhang M, Mal N, Kiedrowski M, et al. SDF-1 expression by mesenchymal stem cells results in trophic support of cardiac myocytes after myocardial infarction. FASEB J. 2007 May 11; [Epub ahead of print].
  • 34
    Noiseux N, Gnecchi M, Lopez-Ilasaca M, et al. Mesenchymal stem cells overexpressing Akt dramatically repair infracted myocardium and improve cardiac function despite infrequent cellular fusion or differentiation. Mol Ther. 2006;14:840850.
  • 35
    Mangi AA, Noiseux N, Kong D, et al. Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts. Nat Med. 2003;9:11951201.
  • 36
    Li W, Ma N, Ong LL, et al. Bcl-2 Engineered MSCs Inhibited Apoptosis and Improved Heart Function. Stem Cells. 2007 May 3; [Epub ahead of print].
  • 37
    Yang J, Zhou W, Zheng W, et al. Effects of myocardial transplantation of marrow mesenchymal stem cells transfected with vascular endothelial growth factor for the improvement of heart function and angiogenesis after myocardial infarction. Cardiology. 2007;107:1729.
  • 38
    Kang HJ, Kim HS, Koo BK, et al. Intracoronary infusion of the mobilized peripheral blood stem cell by G-CSF is better than mobilization alone by G-CSF for improvement of cardiac function and remodeling: 2-year follow up results of the Myocardial Regeneration and Angiogenesis in Myocardial Infarction with G-CSF and Intra-Coronary Stem Cell Infusion (MAGIC Cell) 1 trial. Am Heart J. 2007;153:237.e1237.e8.
  • 39
    Choi JH, Choi J, Lee WS, et al. Lack of additional benefit of intracoronary transplantation of autologous peripheral blood stem cell in patients with acute myocardial infarction. Circ J. 2007;71:486494.
  • 40
    Madonna R, Rinaldi L, Rossi C, et al. Prostacyclin improves transcoronary myocardial delivery of adipose tissue-derived stromal cells. Eur Heart J. 2006;27:20542061.
  • 41
    Nyolczas N, Gyongyosi M, Beran G, et al. Design and rationale for the Myocardial Stem Cell Administration After Acute Myocardial Infarction (MYSTAR) Study: a multicenter, prospective, randomized, single-blind trial comparing early and late intracoronary or combined (percutaneous intramyocardial and intracoronary) administration of nonselected autologous bone marrow cells to patients after acute myocardial infarction. Am Heart J. 2007;153:212.e1212.e7.
  • 42
    Suzuki R, Li TS, Mikamo A, et al. The reduction of hemodynamic loading assists self-regeneration of the injured heart by increasing cell proliferation, inhibiting cell apoptosis, and inducing stem-cell recruitment. J Thorac Cardiovasc Surg. 2007;133:10511058.